Study List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Report Bug
Study List
You are on Page 781 of 796:
771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791

Clinical Studies

NCT Number Gene Therapy Sponsor Status Brief Title Phase View
NCT00086866 European Organisation for Research and Treatment of Cancer - EORTC UNKNOWN Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery PHASE2 View
NCT00086827 National Cancer Institute (NCI) COMPLETED Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer PHASE2 View
NCT00086658 GlaxoSmithKline COMPLETED Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES) PHASE3 View
NCT00086632 Unither Pharmaceuticals TERMINATED Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment PHASE2 View
NCT00086606 Genentech, Inc. TERMINATED A Safety and Efficacy Study of Xolair in Peanut Allergy PHASE2 View
NCT00086593 GlaxoSmithKline COMPLETED Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia PHASE3 View
NCT00086567 Positive Gene Therapy National Cancer Institute (NCI) COMPLETED Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers View
NCT00086502 Positive Gene Therapy Merck Sharp & Dohme LLC COMPLETED Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus PHASE3 View
NCT00086450 Positive Gene Therapy Valentin Fuster UNKNOWN Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes (FREEDOM) PHASE3 View
NCT00086359 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV PHASE3 View
NCT00086333 Seagen Inc. COMPLETED FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma PHASE2 View
NCT00086320 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. COMPLETED A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia. PHASE3 View
NCT00086294 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED ACP-103 to Treat Parkinson's Disease PHASE2 View
NCT00086268 Novartis Pharmaceuticals COMPLETED Non-small Cell Lung Cancer Study US75 (Z-PACT) PHASE3 View
NCT00086216 Positive Gene Therapy Callisto Pharmaceuticals COMPLETED Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma PHASE1 View
NCT00086203 Point Therapeutics COMPLETED Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL) PHASE2 View
NCT00086151 Positive Gene Therapy National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Identifying Low-Risk Patients With Pulmonary Embolism View
NCT00086112 Positive Gene Therapy Johnson & Johnson Pharmaceutical Research & Development, L.L.C. COMPLETED Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy. PHASE3 View
NCT00086060 University of Michigan COMPLETED Pain Management Techniques for Fibromyalgia PHASE1 View
NCT00086034 Pharmacyclics LLC. COMPLETED Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma PHASE2 View
NCT00085995 National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) COMPLETED Progression of Spinal Fusion in Ankylosing Spondylitis View
NCT00085969 AstraZeneca COMPLETED Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus PHASE2 View
NCT00085956 Eli Lilly and Company COMPLETED Effects of Arzoxifene on Bone Mass and the Uterus PHASE3 View
NCT00085904 GlaxoSmithKline COMPLETED Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas PHASE1 View
NCT00085800 Medical University of South Carolina COMPLETED Dietary Fiber and Cardiovascular Inflammatory Markers View
NCT00085761 NeurogesX TERMINATED Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy PHASE3 View
NCT00085735 Children's Oncology Group COMPLETED Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma PHASE3 View
NCT00085657 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Brain Electrical Stimulation to Enhance Recovery After Stroke View
NCT00085566 Memorial Sloan Kettering Cancer Center COMPLETED Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer PHASE1 View
NCT00085358 National Cancer Institute (NCI) COMPLETED Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) PHASE1 View
NCT00085332 Positive Gene Therapy Gynecologic Oncology Group COMPLETED Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) PHASE2 View
NCT00085293 National Cancer Institute (NCI) COMPLETED Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 PHASE2 View
NCT00085202 St. Jude Children's Research Hospital COMPLETED Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor PHASE3 View
NCT00085150 Positive Gene Therapy National Cancer Institute (NCI) COMPLETED LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma PHASE1 View
NCT00085059 Positive Gene Therapy European Organisation for Research and Treatment of Cancer - EORTC TERMINATED Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma PHASE2 View
NCT00085020 Jonsson Comprehensive Cancer Center COMPLETED GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu PHASE1 View
NCT00084903 M.D. Anderson Cancer Center COMPLETED Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears NA View
NCT00084734 Roswell Park Cancer Institute COMPLETED Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors PHASE1 View
NCT00084695 Positive Gene Therapy Milton S. Hershey Medical Center UNKNOWN Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases PHASE2 View
NCT00084669 Massachusetts General Hospital COMPLETED Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer NA View
NCT00084656 Bristol-Myers Squibb COMPLETED Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma PHASE2 View
NCT00084604 Positive Gene Therapy National Cancer Institute (NCI) COMPLETED Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma PHASE2 View
NCT00084461 National Cancer Institute (NCI) TERMINATED Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors PHASE2 View
NCT00084435 SWOG Cancer Research Network WITHDRAWN S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer PHASE2 View
NCT00084318 Positive Gene Therapy Radiation Therapy Oncology Group COMPLETED Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck PHASE2 View
NCT00084305 Positive Gene Therapy National Human Genome Research Institute (NHGRI) ACTIVE_NOT_RECRUITING Analysis of Specimens From Individuals With Pulmonary Fibrosis View
NCT00084292 The Hospital for Sick Children RECRUITING Database for Stroke in Infants and Children: the International Pediatric Stroke Study View
NCT00084266 Pfizer COMPLETED Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) PHASE4 View
NCT00084227 Pfizer COMPLETED Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America PHASE2 View
NCT00084058 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV PHASE1 View
NCT00084032 National Institute of Allergy and Infectious Diseases (NIAID) WITHDRAWN Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV NA View
NCT00083993 Wyeth is now a wholly owned subsidiary of Pfizer TERMINATED Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer PHASE3 View
NCT00083967 Merck Sharp & Dohme LLC TERMINATED Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment PHASE2 View
NCT00083902 University of Arkansas COMPLETED Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy PHASE2 View
NCT00083850 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Genetics and Cardiovascular Reactivity in Young Twins View
NCT00083759 Biogen TERMINATED Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate PHASE2 View
NCT00083733 Positive Gene Therapy National Cancer Institute (NCI) COMPLETED Genetic and Protein Profiling in Normal and Cancerous Breast Tissue View
NCT00083720 Eli Lilly and Company COMPLETED Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy PHASE2 View
NCT00083694 University of Arkansas COMPLETED Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia PHASE2 View
NCT00083668 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. COMPLETED Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia PHASE3 View
NCT00083603 Positive Gene Therapy National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults PHASE1 View
NCT00083551 University of Arkansas COMPLETED UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy PHASE3 View
NCT00083460 Positive Gene Therapy University of Arkansas COMPLETED Study of Combination PS-341 and Thalidomide in Multiple Myeloma PHASE1 View
NCT00083434 Positive Gene Therapy Johnson & Johnson Pharmaceutical Research & Development, L.L.C. TERMINATED Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy PHASE3 View
NCT00083395 Positive Gene Therapy National Institutes of Health Clinical Center (CC) COMPLETED Isoproterenol Challenge to Detect Arrhythmogenic Right Ventricular Cardiomyopathy View
NCT00083369 Positive Gene Therapy University of Alabama at Birmingham COMPLETED Genetic and Environmental Determinants of Triglycerides (GOLDN) View
NCT00083356 Positive Gene Therapy National Institute of Nursing Research (NINR) COMPLETED Bradykinin Receptors and Pain PHASE2 View
NCT00083304 Spectrum Pharmaceuticals, Inc COMPLETED Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer PHASE3 View
NCT00083161 Positive Gene Therapy Gundersen Lutheran Health System COMPLETED Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer PHASE2 View
NCT00083135 Positive Gene Therapy Children's Hospital Los Angeles COMPLETED N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation PHASE1 View
NCT00083057 Positive Gene Therapy National Institutes of Health Clinical Center (CC) COMPLETED Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck PHASE1 View
NCT00083018 Royal Marsden NHS Foundation Trust UNKNOWN Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer PHASE2 View
NCT00083005 National Institutes of Health Clinical Center (CC) COMPLETED Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate PHASE2 View
NCT00082966 Positive Gene Therapy National Cancer Institute (NCI) COMPLETED Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma PHASE2 View
NCT00082758 Positive Gene Therapy Children's Oncology Group COMPLETED hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma PHASE2 View
NCT00082732 M.D. Anderson Cancer Center COMPLETED Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer PHASE1 View
NCT00082706 M.D. Anderson Cancer Center ACTIVE_NOT_RECRUITING Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant PHASE2 View
NCT00082667 Vanderbilt-Ingram Cancer Center TERMINATED Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast PHASE2 View
NCT00082602 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. COMPLETED Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease PHASE3 View
NCT00082550 National Institute of Mental Health (NIMH) COMPLETED Serotonin Transporters in Obsessive-Compulsive-Related Disorders View
NCT00082459 Positive Gene Therapy Agenus Inc. TERMINATED Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma PHASE2 View
NCT00082433 R-Pharm COMPLETED Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer PHASE3 View
NCT00082420 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) COMPLETED Retinol Equivalence of Plant Carotenoids in Children View
NCT00082394 Positive Gene Therapy GlaxoSmithKline COMPLETED A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV PHASE4 View
NCT00082368 National Cancer Institute (NCI) COMPLETED PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy PHASE2 View
NCT00082303 Positive Gene Therapy National Center for Complementary and Integrative Health (NCCIH) COMPLETED Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma PHASE1 View
NCT00082251 Kos Pharmaceuticals COMPLETED Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST PHASE3 View
NCT00082212 Eli Lilly and Company TERMINATED A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma PHASE2 View
NCT00082160 Positive Gene Therapy National Center for Complementary and Integrative Health (NCCIH) COMPLETED Brain Imaging Technology to Examine the Effects of Meditation View
NCT00082134 Genzyme, a Sanofi Company COMPLETED Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel PHASE2 View
NCT00082095 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. TERMINATED To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older PHASE3 View
NCT00082069 U.S. Army Medical Research and Development Command COMPLETED Invaplex 50 Vaccine Dose-Ranging PHASE1 View
NCT00081861 M.D. Anderson Cancer Center COMPLETED Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma PHASE2 View
NCT00081835 National Eye Institute (NEI) COMPLETED Evaluation and Treatment of Eye Complications of Vaccinia Vaccination PHASE2 View
NCT00081757 University of Arkansas COMPLETED An Open Protocol for the Compassionate Use of Thalidomide PHASE1 View
NCT00081705 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Estrogen Receptor Variants, HDL, and Atherosclerosis View
NCT00081692 Virginia Commonwealth University COMPLETED Longitudinal Cardiac Outcomes and Body Composition View
NCT00081666 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Logical Analysis of Data and Cardiac Surgery Risk View
NCT00081458 Shire COMPLETED Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome PHASE3 View
NCT00081432 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Language and Emotional Function in Patients With Temporal Lobe Epilepsy View
NCT00081367 Positive Gene Therapy University of Pennsylvania COMPLETED Community-Based Cognitive Therapy for Suicide Attempters PHASE3 View
NCT00081302 Positive Gene Therapy Radiation Therapy Oncology Group COMPLETED Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer PHASE2 View
NCT00081250 Alliance for Clinical Trials in Oncology COMPLETED Creatine in Treating Patients With Cancer-Associated Weight Loss PHASE3 View
NCT00081159 Positive Gene Therapy M.D. Anderson Cancer Center COMPLETED Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases PHASE2 View
NCT00081133 Memorial Sloan Kettering Cancer Center COMPLETED Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia PHASE1 View
NCT00081094 Washington University School of Medicine COMPLETED Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer NA View
NCT00081068 Jonsson Comprehensive Cancer Center WITHDRAWN Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia PHASE2 View
NCT00081003 Royal Marsden NHS Foundation Trust COMPLETED Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast Cancer NA View
NCT00080951 Alliance for Clinical Trials in Oncology COMPLETED Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer PHASE2 View
NCT00080860 National Institutes of Health Clinical Center (CC) COMPLETED Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer NA View
NCT00080834 Daiichi Sankyo COMPLETED DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma PHASE2 View
NCT00080795 Positive Gene Therapy M.D. Anderson Cancer Center COMPLETED Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium PHASE2 View
NCT00080756 City of Hope Medical Center ACTIVE_NOT_RECRUITING Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease PHASE2 View
NCT00080535 National Cancer Institute (NCI) COMPLETED Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas PHASE2 View
NCT00080457 Encysive Pharmaceuticals COMPLETED Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension PHASE3 View
NCT00080418 INSYS Therapeutics Inc COMPLETED Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) in Patients With Advanced Cancer PHASE1 View
NCT00080405 Positive Gene Therapy Millennium Pharmaceuticals, Inc. COMPLETED Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma PHASE1 View
NCT00080392 Positive Gene Therapy National Heart, Lung, and Blood Institute (NHLBI) COMPLETED EW-A-401 to Treat Intermittent Claudication PHASE1 View
NCT00080366 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Octanol to Treat Essential Tremor PHASE2 View
NCT00080327 Otsuka Pharmaceutical Development & Commercialization, Inc. COMPLETED Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia PHASE4 View
NCT00080158 New York State Psychiatric Institute COMPLETED Treatment of Adolescent Suicide Attempters (TASA) PHASE2 View
NCT00080132 Medical Research Laboratories International TERMINATED Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy PHASE2 View
NCT00080106 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients PHASE2 View
NCT00080093 National Institute of Allergy and Infectious Diseases (NIAID) UNKNOWN Increasing Condom Use in People at Risk for HIV Infection NA View
NCT00080067 Positive Gene Therapy National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Rhythm Perception and Generation View
NCT00080028 Positive Gene Therapy Pharmacyclics LLC. TERMINATED Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer PHASE1 View
NCT00080002 Enzon Pharmaceuticals, Inc. TERMINATED Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction PHASE2 View
NCT00079950 Enzon Pharmaceuticals, Inc. SUSPENDED Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma PHASE2 View
NCT00079859 Positive Gene Therapy Medical Research Laboratories International TERMINATED Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy PHASE2 View
NCT00079833 AstraZeneca COMPLETED Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome PHASE3 View
NCT00079820 Positive Gene Therapy Sanofi Pasteur, a Sanofi Company COMPLETED Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults PHASE1 View
NCT00079794 Positive Gene Therapy National Center for Complementary and Integrative Health (NCCIH) COMPLETED Iscar for Supplemental Care in Stage IV Lung Cancer PHASE2 View
NCT00079768 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Alemtuzumab to Treat Sporadic Inclusion Body Myositis PHASE2 View
NCT00079703 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Diet, Genetics, and CVD Risk Factor Response in Blacks View
NCT00079651 Menorah Park COMPLETED Montessori-Based Activities for Elderly Persons With Dementia PHASE2 View
NCT00079560 Positive Gene Therapy National Institute on Drug Abuse (NIDA) COMPLETED Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS PHASE1 View
NCT00079534 Positive Gene Therapy National Center for Complementary and Integrative Health (NCCIH) COMPLETED Distant Healing for HIV/AIDS NA View
NCT00079495 Positive Gene Therapy Neurocrine Biosciences COMPLETED Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS) PHASE2 View
NCT00079469 National Institutes of Health Clinical Center (CC) COMPLETED Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke NA View
NCT00079456 National Cancer Institute (NCI) COMPLETED Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma PHASE2 View
NCT00079404 National Cancer Institute (NCI) COMPLETED 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia PHASE1 View
NCT00079261 Positive Gene Therapy European Organisation for Research and Treatment of Cancer - EORTC COMPLETED Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma PHASE2 View
NCT00079235 National Cancer Institute (NCI) COMPLETED CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer PHASE2 View
NCT00079157 Positive Gene Therapy Abramson Cancer Center at Penn Medicine COMPLETED Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer PHASE1 View
NCT00079118 Positive Gene Therapy Alliance for Clinical Trials in Oncology COMPLETED Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer PHASE2 View
NCT00079105 Positive Gene Therapy Newcastle-upon-Tyne Hospitals NHS Trust COMPLETED A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years PHASE2 View
NCT00079092 Positive Gene Therapy Wake Forest University Health Sciences COMPLETED Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma PHASE2 View
NCT00079066 Positive Gene Therapy NCIC Clinical Trials Group COMPLETED Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer PHASE3 View
NCT00079027 Positive Gene Therapy University Hospital Birmingham UNKNOWN Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) PHASE3 View
NCT00078858 Fred Hutchinson Cancer Center COMPLETED Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant PHASE1 View
NCT00078832 Queen Mary University of London COMPLETED Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer PHASE3 View
NCT00078806 Positive Gene Therapy Amgen TERMINATED Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis PHASE3 View
NCT00078793 Amgen COMPLETED Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis View
NCT00078767 Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) COMPLETED Pharmacologic Treatment of PTSD in Sexually Abused Children PHASE3 View
NCT00078728 Johns Hopkins University COMPLETED Family-Based Prevention Program for Childhood Anxiety NA View
NCT00078559 University of Wisconsin, Madison COMPLETED Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults PHASE1 View
NCT00078533 Baylor College of Medicine COMPLETED Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant PHASE1 View
NCT00078520 Baylor College of Medicine COMPLETED Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells PHASE1 View
NCT00078494 National Institutes of Health Clinical Center (CC) COMPLETED Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer PHASE1 View
NCT00078468 Pfizer COMPLETED Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment PHASE2 View
NCT00078403 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) PHASE2 View
NCT00078351 National Institute of Dental and Craniofacial Research (NIDCR) COMPLETED Synvisc to Treat Osteoarthritis of the Temporomandibular Joint PHASE2 View
NCT00078312 Cephalon COMPLETED Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder PHASE3 View
NCT00078260 Eli Lilly and Company COMPLETED A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer PHASE3 View
NCT00078234 Positive Gene Therapy Genta Incorporated COMPLETED Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia PHASE1 View
NCT00078195 Positive Gene Therapy National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies PHASE2 View
NCT00078169 Positive Gene Therapy Yale University COMPLETED Motivational Enhancement for Spanish Speaking Individuals - 1 PHASE3 View
NCT00078156 New York State Psychiatric Institute COMPLETED Women's Treatment for Trauma and Substance Use Disorders - 1 PHASE3 View
NCT00078104 National Institute of Dental and Craniofacial Research (NIDCR) COMPLETED Prostanoid Levels After Medication to Prevent Pain Following Third Molar (Wisdom Tooth) Extraction PHASE2 View
NCT00077961 Positive Gene Therapy Genzyme, a Sanofi Company TERMINATED Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHL PHASE1 View
NCT00077935 Winston Laboratories COMPLETED Civamide in OA of the Knee(s) PHASE3 View
NCT00077857 Hoffmann-La Roche COMPLETED A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer PHASE2 View
NCT00077818 Sanofi COMPLETED Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE) PHASE4 View
NCT00077805 Sanofi COMPLETED PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin) PHASE4 View
NCT00077792 Positive Gene Therapy Sanofi COMPLETED Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25) PHASE3 View
NCT00077766 Hoffmann-La Roche COMPLETED A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. PHASE3 View
NCT00077558 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins COMPLETED 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome PHASE1 View
NCT00077532 National Institutes of Health Clinical Center (CC) COMPLETED Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma PHASE2 View
NCT00077493 MedImmune LLC SUSPENDED BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma PHASE1 View
NCT00077467 National Cancer Institute (NCI) COMPLETED Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia PHASE1 View
NCT00077402 Positive Gene Therapy Cancer Therapeutics Research Group COMPLETED Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer PHASE2 View
NCT00077350 National Cancer Institute (NCI) COMPLETED A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer PHASE2 View
NCT00077259 Positive Gene Therapy Memorial Sloan Kettering Cancer Center COMPLETED Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer PHASE2 View
NCT00077233 Positive Gene Therapy Alliance for Clinical Trials in Oncology TERMINATED FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum PHASE3 View
NCT00077220 Positive Gene Therapy GERCOR - Multidisciplinary Oncology Cooperative Group UNKNOWN Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer PHASE3 View
NCT00077194 Positive Gene Therapy National Cancer Institute (NCI) COMPLETED FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma PHASE2 View
NCT00077168 Positive Gene Therapy Institute of Cancer Research, United Kingdom UNKNOWN Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole PHASE2 View
NCT00077103 Case Comprehensive Cancer Center TERMINATED Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer PHASE1 View
NCT00077051 Positive Gene Therapy University of Miami COMPLETED Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat) PHASE1 View
NCT00076960 Positive Gene Therapy InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company NO_LONGER_AVAILABLE Compassionate Use of Stanate (TM) [Stannsoporfin] View
NCT00076934 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Safety of RG2077 in Patients With Multiple Sclerosis PHASE1 View
NCT00076869 Merck Sharp & Dohme LLC COMPLETED MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037) PHASE2 View
NCT00076856 Merck Sharp & Dohme LLC COMPLETED Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) PHASE2 View
NCT00076804 Johns Hopkins University TERMINATED Helping HIV Infected Patients in South Africa Adhere to Drug Regimens PHASE2 View
NCT00076635 InterMune TERMINATED An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF PHASE3 View
NCT00076557 Avigen TERMINATED Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B PHASE1 View
NCT00076518 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART) PHASE2 View
NCT00076505 National Human Genome Research Institute (NHGRI) COMPLETED Cell Studies of Parkinson's Disease View
NCT00076492 University of Rochester COMPLETED NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485 PHASE2 View
NCT00076466 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Brain Changes Associated With Learning a Motor Task View